JPMorgan
http://www.jpmorgan.comJPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $1.5 trillion and operations in more than 50 countries. The firm is a leader in investment banking, financial services for consumers, small business and commercial banking, financial transaction processing, asset management, and private equity.
-
-
-
-
-
-
-
UPDATE: JPMorgan Upgrades Gilead Sciences (GILD) to Overweight; 'Becoming Less Controversial with Increased Visibility'
-
-
-
-
-
-
-
Gilead shares slide after FDA knocks back rheumatoid arthritis drug
-
-
-
-
-
-
-
Thermo Fisher agrees to buy genetic tester Qiagen in $11.5 billion deal
-
-
-
-
-
-
-
Bristol-Myers to buy Celgene for $74 billion in largest biopharma deal
-
-
-
-
-
-
-
$11 billion biotech binge fuels forecasts of 2018 M&A surge
-
-
-
-
-
-
-
Pre-Open Stock Movers 12/16: (JBL) (HZNP) (TXMD) Higher; (AGIO) (VCEL) (FNSR) Lower (more...)
-
-
-
-
-
-
-
Notable Analyst Rating Changes 2/11: (TWX) (BDX) (LVLT) Upgraded; (V) (SEMI) (ARMH) Downgraded
-
208,913 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All